08:54 AM EDT, 04/15/2024 (MT Newswires) -- Health care stocks rose in premarket activity Monday as the Health Care Select Sector SPDR Fund (XLV) was up 0.6% and the iShares Biotechnology ETF (IBB) was 0.3% higher recently.

Neumora Therapeutics ( NMRA ) shares were declining by over 14% after the company said the US Food and Drug Administration has placed a clinical hold on the phase 1 trial of its NMRA-266 potential brain disease treatment after the emergence of pre-clinical data showing convulsions in rabbits.